1. Understand the incidence of vestibular schwannoma in the US and European population.
2. Elucidate the differences in patient reported quality of life in patients with vestibular schwannoma undergoing a variety of treatments.
3. Review tools available to predict future loss of hearing or other adverse effects in patients with vestibular schwannoma.
11/08/2023 - 7:30am to 8:30am CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Michael Link, MD